Speciality Medicines Limited operates in the pharmaceutical sector, primarily engaged in marketing, distribution, export and contract manufacturing of pharmaceutical formulations. The company earns revenue through the sale of generic medicines and pharmaceutical products across multiple therapeutic segments. Its product portfolio covers treatments for cardiology, dermatology, respiratory diseases, infections, neurological disorders and chronic conditions. The company operates with a diversified business model involving loan-license manufacturing arrangements and global product registrations to expand its reach in international markets.

Speciality Medicines an Book Built Issue, amounting to ₹ 29.14 Crore,consisting entirely an fresh issue of 0.24 crore shares of  ₹ 29.14 crores.The subscription period for the Speciality Medicines IPO opens on March 20, 2026, and closes on March 24, 2026. The allotment is expected to be finalized on or about 25 March 2026, Wednesday, and the shares will be listed on the BSE SME with a tentative listing date set on or about Monday, March 30, 2026.

The Share Price Band of Speciality Medicines IPO is set at ₹117 to ₹124 per share  per equity share. The Market Capitalisation of the Speciality Medicines at IPO price of ₹124  per equity share will be ₹ 108.94 Cr. The lot size of the IPO is 1,000 shares. Retail investors are required to invest a minimum of ₹ 248,000,  2 lots ( 2,000 shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 3 lots ( 3,000 shares), amounting to ₹ 372,000.

UNISTONE CAPITAL PRIVATE LIMITED, the book running lead manager of the Speciality Medicines. while SKYLINE FINANCIAL SERVICES PRIVATE LIMITED is the registrar for the issue.The Market Maker of the company is  Aikyam Capital Private Limited.

Speciality Medicines Limited IPO GMP Today
The Grey Market Premium of Speciality Medicines IPO is expected to be ₹0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Speciality Medicines Limited IPO Live Subscription Status Today: Real-Time Update
The subscription period for the Speciality Medicines IPO opens on March 20, 2026

Speciality Medicines Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Speciality Medicines IPO allotment date is 25 March 2026, Wednesday, Speciality Medicines IPO Allotment will be out on 25 March 2026, Wednesday, and will be live on Registrar Website from the allotment date.
SKYLINE FINANCIAL SERVICES PRIVATE LIMITED IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Speciality Medicines IPO from the dropdown list of IPO
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Speciality Medicines Limited IPO
Speciality Medicines to utilise the Net Proceeds towards the following objects:
1. ₹1,267.64 Lakhs is required for Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje: Manda, Tal. Umargam, Dist. Valsad, Gujarat
2. ₹299.25 Lakhs is required for Product Registration in International Markets and Product Development for sale in international markets
3. ₹165.61 Lakhs is required for Funding for Marketing and Promotional Activities
4. ₹800.00 Lakhs is required for To Meet Working Capital Requirements.
5. General Corporate Expenses

Refer to Speciality Medicines Limited RHP for more details about the Company.